Stericycle (NASDAQ:SRCL) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Stericycle (NASDAQ:SRCL) in a report published on Sunday. The firm issued a hold rating on the business services provider’s stock.

Other analysts have also recently issued research reports about the stock. Royal Bank of Canada reiterated a sector perform rating and set a $62.00 price target (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods boosted their price target on Stericycle from $135.00 to $142.00 and gave the company an outperform rating in a research report on Tuesday, June 4th. Robert W. Baird reduced their price objective on Stericycle from $62.00 to $55.00 and set a neutral rating for the company in a research note on Friday, April 26th. Finally, Truist Financial lifted their target price on Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research note on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Hold and a consensus target price of $74.00.

Stericycle Trading Down 0.4 %

Shares of Stericycle stock opened at $58.25 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a fifty day simple moving average of $53.25 and a 200-day simple moving average of $51.22. The stock has a market cap of $5.41 billion, a price-to-earnings ratio of -264.77, a PEG ratio of 3.15 and a beta of 1.11. Stericycle has a 12-month low of $37.78 and a 12-month high of $59.45.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.49 earnings per share. On average, equities analysts forecast that Stericycle will post 2.32 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of SRCL. Boston Partners boosted its position in shares of Stericycle by 57.7% during the 1st quarter. Boston Partners now owns 15,520 shares of the business services provider’s stock worth $819,000 after purchasing an additional 5,681 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Stericycle in the first quarter valued at about $209,000. SkyView Investment Advisors LLC boosted its holdings in Stericycle by 11.9% during the first quarter. SkyView Investment Advisors LLC now owns 16,051 shares of the business services provider’s stock worth $847,000 after buying an additional 1,704 shares in the last quarter. Earnest Partners LLC grew its position in Stericycle by 12.4% during the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after buying an additional 271,025 shares during the period. Finally, Capital Research Global Investors increased its holdings in Stericycle by 11.4% in the first quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock valued at $351,732,000 after buying an additional 679,974 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.